Duality Advisers’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-283,042
Closed -$2.66M 562
2023
Q1
$2.66M Buy
283,042
+125,776
+80% +$1.48M 0.3% 122
2022
Q4
$1.92M Buy
+157,266
New +$1.96M 0.22% 169
2022
Q3
Sell
-62,327
Closed -$1.22M 590
2022
Q2
$1.22M Buy
+62,327
New +$1.48M 0.12% 314
2022
Q1
Sell
-84,175
Closed -$2.39M 682
2021
Q4
$2.39M Buy
+84,175
New +$2.62M 0.26% 147
2021
Q3
Sell
-34,306
Closed -$1.19M 584
2021
Q2
$1.19M Sell
34,306
-88,182
-72% -$2.91M 0.11% 304
2021
Q1
$3.61M Buy
122,488
+63,696
+108% +$1.96M 0.31% 97
2020
Q4
$1.8M Sell
58,792
-23,698
-29% -$723K 0.13% 240
2020
Q3
$2.3M Buy
+82,490
New +$2.09M 0.15% 194

Other funds holding ELAN

Duality Advisers's ELAN Position: Q2 2023 in Review

Duality Advisers sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 283,042 shares — an estimated $2.66M sold.

Duality Advisers first reported a position in ELAN in Q3 2020 and held it in 8 quarters. The position peaked at $3.61M in Q1 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Duality Advisers reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Duality Advisers sold 283,042 Elanco Animal Health shares in Q2 2023, an estimated $2.66M.
  • Duality Advisers first reported a position in Elanco Animal Health in Q3 2020 and held it in 8 quarters.
  • Duality Advisers's Elanco Animal Health position peaked at $3.61M in Q1 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Duality Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.